FIELD: chemistry.
SUBSTANCE: invention relates to a method of producing a crystalline solid compound 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione, having structure (I), where the crystalline solid compound has an X-ray powder diffraction pattern with characteristic peaks expressed in degrees 2θ ± 0.2, at 8.07; 10.81; 14.68 and 22.07. Method is carried out by (a) forming suspension 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione in aqueous ethanol at temperature of 35 to 45 °C, (b) cooling the suspension to room temperature, (c) filtering the suspension to separate the compacted solid precipitate, (d) washing the pressed sediment with aqueous ethanol and (e) drying the pressed sediment under vacuum to constant weight.
EFFECT: obtaining a thermodynamically stable polymorphic form of 6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione.
4 cl, 5 tbl, 4 dwg, 1 ex
Title | Year | Author | Number |
---|---|---|---|
TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS OF ITS USE | 2020 |
|
RU2747991C1 |
TETRAHYDROPYRANYL AMINO-PYRROLOPYRIMIDINONE AND METHODS FOR USE THEREOF | 2015 |
|
RU2715421C2 |
PREPARATIONS OF {2-[(1S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHANESULFONYLETHYL]-3-OXO-2,3-DIHYDRO-1H-ISOINDOL-4-YL} AMIDE OF CYCLOPROPANECARBOXYLIC ACID | 2012 |
|
RU2627471C2 |
METHODS AND COMPOSITIONS USING IMMUNOMODULATORY COMPOUNDS FOR TREATMENT AND MAINTENANCE OF CANCER AND OTHER DISEASES | 2004 |
|
RU2348407C2 |
HETEROCYCLIC COMPOUNDS AND THEIR APPLICATION | 2016 |
|
RU2744897C2 |
COMBINATION OF A HISTONE DEACETYLASE INHIBITOR AND A PROTEIN KINASE INHIBITOR AND PHARMACEUTICAL APPLICATION THEREOF | 2019 |
|
RU2770754C1 |
INTERMEDIATE CHEMICAL COMPOUNDS AND METHODS FOR PRODUCING COMPOUNDS | 2013 |
|
RU2635359C2 |
PHARMACEUTICAL COMBINATIONS FOR TREATING A MALIGNANT TUMOR | 2017 |
|
RU2726367C2 |
ABT-263 CRYSTALLINE FORMS AND SOLVATES FOR TREATMENT OF BCL-2 PROTEIN RELATED DISEASES | 2010 |
|
RU2551376C2 |
COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | 2016 |
|
RU2759963C2 |
Authors
Dates
2024-06-19—Published
2019-10-23—Filed